Strensiq (asfotase alfa) — United Healthcare
perinatal/infantile-onset hypophosphatasia
Initial criteria
- Diagnosis of perinatal/infantile-onset hypophosphatasia OR diagnosis of juvenile-onset hypophosphatasia
Reauthorization criteria
- Documentation of positive clinical response to Strensiq therapy
Approval duration
12 months